Yuasa Bruna Kaori, Magalhães Luis Eduardo, de Oliveira Paula Gabriela Sousa, Yokota Lais Gabriela, Cardoso Pedro Andriolo, Zamoner Welder, Balbi André Luis, Ponce Daniela
Botucatu School of Medicine, São Paulo State University, Botucatu, Brazil.
Clinical Medicine Department, Botucatu School of Medicine, São Paulo State University, Botucatu, Brazil.
Front Nephrol. 2022 May 9;2:896891. doi: 10.3389/fneph.2022.896891. eCollection 2022.
Elderly patients with COVID-19 are at a higher risk of severity and death as not only several comorbidities but also aging itself has been considered a relevant risk factor. Acute kidney injury (AKI), one of the worst complications of SARS-CoV-2 infection, is associated with worse outcomes. Studies on AKI with COVID-19 in Latin-American patients of older age remain scarce.
To determine AKI incidence and the risk factors associated with its development, as well as to compare outcome of elderly patients with or without AKI associated with SARS-CoV-2 infection.
This retrospective cohort study evaluated patients with SARS-CoV2 infection admitted to a Public Tertiary Referral Hospital from 03/01/2020 to 12/31/2020, from admission to resolution (hospital discharge or death). Demographic, clinical, and laboratory data were collected from patients during hospitalization. Daily kidney function assessment was performed by measuring serum creatinine and urine output. AKI was diagnosed according to KDIGO 2012 criteria.
Of the 347 patients with COVID-19 admitted to our hospital during the study period, 52.16% were elderly, with a median age of 72 years (65- 80 years). In this age group, most patients were males (56.91%), hypertensive (73.48%), and required ICU care (55.25%). AKI overall incidence in the elderly was 56.9%, with higher frequency in ICU patients (p < 0.001). There was a predominance of KDIGO 3 (50.48%), and acute kidney replacement therapy (AKRT) was required by 47.57% of the patients. The risk factors associated with AKI development were higher baseline creatinine level (OR 10.54, CI 1.22 -90.61, p = 0.032) and need for mechanical ventilation (OR 9.26, CI 1.08-79.26, p = 0.042). Mortality was also more frequent among patients with AKI (46.41%vs24.7%, p < 0.0001), with death being associated with CPK level (OR 1.009, CI 1.001-1.017, p = 0.042), need for mechanical ventilation (OR 17.71, CI 1.13-277.62, p = 0.002) and KDIGO 3 (OR 2.017 CI 1.039 -3.917, p = 0.038).
AKI was frequent among the elderly hospitalized with COVID-19 and its risk factors were higher baseline creatinine and need for mechanical ventilation. AKI was independently associated with a higher risk of death.
患有新冠肺炎的老年患者出现重症和死亡的风险更高,这是因为多种合并症以及衰老本身都被视为相关风险因素。急性肾损伤(AKI)是严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染最严重的并发症之一,与更差的预后相关。关于拉丁美洲老年新冠肺炎患者急性肾损伤的研究仍然很少。
确定急性肾损伤的发病率及其发生的相关风险因素,并比较感染SARS-CoV-2的老年患者伴有或不伴有急性肾损伤的预后。
这项回顾性队列研究评估了2020年1月3日至2020年12月31日入住一家公立三级转诊医院的SARS-CoV-2感染患者,从入院到病情缓解(出院或死亡)。在患者住院期间收集人口统计学、临床和实验室数据。通过测量血清肌酐和尿量进行每日肾功能评估。根据2012年改善全球肾脏病预后组织(KDIGO)标准诊断急性肾损伤。
在研究期间入住我院的347例新冠肺炎患者中,52.16%为老年人,中位年龄为72岁(65 - 80岁)。在这个年龄组中,大多数患者为男性(56.91%),患有高血压(73.48%),并需要重症监护病房(ICU)护理(55.25%)。老年人急性肾损伤的总体发病率为56.9%,在ICU患者中发生率更高(p < 0.001)。以KDIGO 3期为主(50.48%),47.57%的患者需要进行急性肾替代治疗(AKRT)。与急性肾损伤发生相关的风险因素为基线肌酐水平较高(比值比[OR]10.54,95%置信区间[CI]1.22 - 90.61,p = 0.032)和需要机械通气(OR 9.26,CI 1.08 - 79.26,p = 0.042)。急性肾损伤患者的死亡率也更高(46.41%对24.7%,p < 0.0001),死亡与肌酸磷酸激酶(CPK)水平(OR 1.009,CI 1.001 - 1.017,p = 0.042)、需要机械通气(OR 17.71,CI 1.13 - 277.62,p = 0.002)和KDIGO 3期(OR 2.017,CI 1.039 - 3.917,p = 0.038)相关。
在因新冠肺炎住院的老年人中,急性肾损伤很常见,其风险因素为较高的基线肌酐水平和需要机械通气。急性肾损伤与更高的死亡风险独立相关。